<?xml version="1.0" encoding="UTF-8"?>
<entry>
	<accession>MF2100014</accession>
	<general>
		<name>Superoxide dismutase (SOD)</name>
		<pdb_id>2c9v</pdb_id>
		<exp_method>X-ray</exp_method>
		<resolution>1.07</resolution>
		<assembly>Homodimer</assembly>
		<source_organism>Homo sapiens</source_organism>
		<publication>
			<pmid>16406071</pmid>
			<authors>Strange RW, Antonyuk SV, Hough MA, Doucette PA, Valentine JS, Hasnain SS</authors>
			<title>Variable metallation of human superoxide dismutase: atomic resolution crystal structures of Cu-Zn, Zn-Zn and as-isolated wild-type enzymes.</title>
			<journal>J. Mol. Biol.</journal>
			<year>2006</year>
			<issue>5</issue>
			<volume>356</volume>
			<pages>1152-62</pages>
			<abstract>Human Cu-Zn superoxide dismutase (SOD1) protects cells from the effects of oxidative stress. Mutations in SOD1 are linked to the familial form of amyotrophic lateral sclerosis. Several hypotheses for their toxicity involve the mis-metallation of the enzyme. We present atomic-resolution crystal structures and biophysical data for human SOD1 in three metallation states: Zn-Zn, Cu-Zn and as-isolated. These data represent the first atomic-resolution structures for human SOD1, the first structure of a reduced SOD1, and the first structure of a fully Zn-substituted SOD1 enzyme. Recombinantly expressed as-isolated SOD1 contains a mixture of Zn and Cu at the Cu-binding site. The Zn-Zn structure appears to be at least as stable as the correctly (Cu-Zn) metallated enzyme. These data raise the possibility that in a cellular environment with low availability of free copper, Zn-Zn may be the preferred metallation state of SOD1 prior to its interaction with the copper chaperone.</abstract>
		</publication>
	</general>
	<function>
		<molecular_function>
			<go>
				<accession>GO:0005507</accession>
				<name>copper ion binding</name>
			</go>
			<go>
				<accession>GO:0042802</accession>
				<name>identical protein binding</name>
			</go>
			<go>
				<accession>GO:0030346</accession>
				<name>protein phosphatase 2B binding</name>
			</go>
			<go>
				<accession>GO:0051087</accession>
				<name>protein-folding chaperone binding</name>
			</go>
			<go>
				<accession>GO:0031267</accession>
				<name>small GTPase binding</name>
			</go>
			<go>
				<accession>GO:0004784</accession>
				<name>superoxide dismutase activity</name>
			</go>
			<go>
				<accession>GO:0008270</accession>
				<name>zinc ion binding</name>
			</go>
		</molecular_function>
		<cellular_component>
			<go>
				<accession>GO:1904115</accession>
				<name>axon cytoplasm</name>
			</go>
			<go>
				<accession>GO:0005737</accession>
				<name>cytoplasm</name>
			</go>
			<go>
				<accession>GO:0031410</accession>
				<name>cytoplasmic vesicle</name>
			</go>
			<go>
				<accession>GO:0005829</accession>
				<name>cytosol</name>
			</go>
			<go>
				<accession>GO:0032839</accession>
				<name>dendrite cytoplasm</name>
			</go>
			<go>
				<accession>GO:0070062</accession>
				<name>extracellular exosome</name>
			</go>
			<go>
				<accession>GO:0005576</accession>
				<name>extracellular region</name>
			</go>
			<go>
				<accession>GO:0005615</accession>
				<name>extracellular space</name>
			</go>
			<go>
				<accession>GO:0005758</accession>
				<name>mitochondrial intermembrane space</name>
			</go>
			<go>
				<accession>GO:0005759</accession>
				<name>mitochondrial matrix</name>
			</go>
			<go>
				<accession>GO:0005739</accession>
				<name>mitochondrion</name>
			</go>
			<go>
				<accession>GO:0043025</accession>
				<name>neuronal cell body</name>
			</go>
			<go>
				<accession>GO:0005654</accession>
				<name>nucleoplasm</name>
			</go>
			<go>
				<accession>GO:0005634</accession>
				<name>nucleus</name>
			</go>
			<go>
				<accession>GO:0005777</accession>
				<name>peroxisome</name>
			</go>
			<go>
				<accession>GO:0032991</accession>
				<name>protein-containing complex</name>
			</go>
		</cellular_component>
		<biological_process>
			<go>
				<accession>GO:0099610</accession>
				<name>action potential initiation</name>
			</go>
			<go>
				<accession>GO:0008089</accession>
				<name>anterograde axonal transport</name>
			</go>
			<go>
				<accession>GO:0006915</accession>
				<name>apoptotic process</name>
			</go>
			<go>
				<accession>GO:0060088</accession>
				<name>auditory receptor cell stereocilium organization</name>
			</go>
			<go>
				<accession>GO:0008340</accession>
				<name>determination of adult lifespan</name>
			</go>
			<go>
				<accession>GO:0035234</accession>
				<name>ectopic germ cell programmed cell death</name>
			</go>
			<go>
				<accession>GO:0007566</accession>
				<name>embryo implantation</name>
			</go>
			<go>
				<accession>GO:0010467</accession>
				<name>gene expression</name>
			</go>
			<go>
				<accession>GO:0006749</accession>
				<name>glutathione metabolic process</name>
			</go>
			<go>
				<accession>GO:0060047</accession>
				<name>heart contraction</name>
			</go>
			<go>
				<accession>GO:0050665</accession>
				<name>hydrogen peroxide biosynthetic process</name>
			</go>
			<go>
				<accession>GO:0006879</accession>
				<name>intracellular iron ion homeostasis</name>
			</go>
			<go>
				<accession>GO:0007626</accession>
				<name>locomotory behavior</name>
			</go>
			<go>
				<accession>GO:0046716</accession>
				<name>muscle cell cellular homeostasis</name>
			</go>
			<go>
				<accession>GO:0002262</accession>
				<name>myeloid cell homeostasis</name>
			</go>
			<go>
				<accession>GO:0045541</accession>
				<name>negative regulation of cholesterol biosynthetic process</name>
			</go>
			<go>
				<accession>GO:0051093</accession>
				<name>negative regulation of developmental process</name>
			</go>
			<go>
				<accession>GO:0050728</accession>
				<name>negative regulation of inflammatory response</name>
			</go>
			<go>
				<accession>GO:0043524</accession>
				<name>negative regulation of neuron apoptotic process</name>
			</go>
			<go>
				<accession>GO:2000242</accession>
				<name>negative regulation of reproductive process</name>
			</go>
			<go>
				<accession>GO:0060052</accession>
				<name>neurofilament cytoskeleton organization</name>
			</go>
			<go>
				<accession>GO:0019228</accession>
				<name>neuronal action potential</name>
			</go>
			<go>
				<accession>GO:0001541</accession>
				<name>ovarian follicle development</name>
			</go>
			<go>
				<accession>GO:0032287</accession>
				<name>peripheral nervous system myelin maintenance</name>
			</go>
			<go>
				<accession>GO:0001890</accession>
				<name>placenta development</name>
			</go>
			<go>
				<accession>GO:0043065</accession>
				<name>positive regulation of apoptotic process</name>
			</go>
			<go>
				<accession>GO:0043085</accession>
				<name>positive regulation of catalytic activity</name>
			</go>
			<go>
				<accession>GO:0001819</accession>
				<name>positive regulation of cytokine production</name>
			</go>
			<go>
				<accession>GO:0043410</accession>
				<name>positive regulation of MAPK cascade</name>
			</go>
			<go>
				<accession>GO:1902177</accession>
				<name>positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway</name>
			</go>
			<go>
				<accession>GO:0050766</accession>
				<name>positive regulation of phagocytosis</name>
			</go>
			<go>
				<accession>GO:0032930</accession>
				<name>positive regulation of superoxide anion generation</name>
			</go>
			<go>
				<accession>GO:0072593</accession>
				<name>reactive oxygen species metabolic process</name>
			</go>
			<go>
				<accession>GO:0008217</accession>
				<name>regulation of blood pressure</name>
			</go>
			<go>
				<accession>GO:0043087</accession>
				<name>regulation of GTPase activity</name>
			</go>
			<go>
				<accession>GO:0051881</accession>
				<name>regulation of mitochondrial membrane potential</name>
			</go>
			<go>
				<accession>GO:0040014</accession>
				<name>regulation of multicellular organism growth</name>
			</go>
			<go>
				<accession>GO:0046620</accession>
				<name>regulation of organ growth</name>
			</go>
			<go>
				<accession>GO:0045859</accession>
				<name>regulation of protein kinase activity</name>
			</go>
			<go>
				<accession>GO:0033081</accession>
				<name>regulation of T cell differentiation in thymus</name>
			</go>
			<go>
				<accession>GO:0060087</accession>
				<name>relaxation of vascular associated smooth muscle</name>
			</go>
			<go>
				<accession>GO:0019430</accession>
				<name>removal of superoxide radicals</name>
			</go>
			<go>
				<accession>GO:0048678</accession>
				<name>response to axon injury</name>
			</go>
			<go>
				<accession>GO:0045471</accession>
				<name>response to ethanol</name>
			</go>
			<go>
				<accession>GO:0009408</accession>
				<name>response to heat</name>
			</go>
			<go>
				<accession>GO:0042542</accession>
				<name>response to hydrogen peroxide</name>
			</go>
			<go>
				<accession>GO:0010033</accession>
				<name>response to organic substance</name>
			</go>
			<go>
				<accession>GO:0000303</accession>
				<name>response to superoxide</name>
			</go>
			<go>
				<accession>GO:0009410</accession>
				<name>response to xenobiotic stimulus</name>
			</go>
			<go>
				<accession>GO:0001895</accession>
				<name>retina homeostasis</name>
			</go>
			<go>
				<accession>GO:0008090</accession>
				<name>retrograde axonal transport</name>
			</go>
			<go>
				<accession>GO:0007605</accession>
				<name>sensory perception of sound</name>
			</go>
			<go>
				<accession>GO:0007283</accession>
				<name>spermatogenesis</name>
			</go>
			<go>
				<accession>GO:0042554</accession>
				<name>superoxide anion generation</name>
			</go>
			<go>
				<accession>GO:0006801</accession>
				<name>superoxide metabolic process</name>
			</go>
			<go>
				<accession>GO:0048538</accession>
				<name>thymus development</name>
			</go>
			<go>
				<accession>GO:0019226</accession>
				<name>transmission of nerve impulse</name>
			</go>
		</biological_process>
	</function>
	<macromolecules>
		<general>
			<nr_of_chains>2</nr_of_chains>
			<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
			<class>Homooligomeric enzymes</class>
			<subclass>Homodimeric enzymes</subclass>
			<note>All chains according to the most probable oligomerization state stored in PDBe were considered.</note>
		</general>
		<chain>
			<id>A</id>
			<name>Superoxide dismutase [Cu-Zn]</name>
			<source_organism>Homo sapiens</source_organism>
			<uniprot>
				<id>P00441</id>
				<start>2</start>
				<end>154</end>
				<coverage>99%</coverage>
				<sequence>MATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ</sequence>
				<length>154</length>
			</uniprot>
			<regions>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>helix</region_name>
					<region_start>55</region_start>
					<region_end>61</region_end>
				</region>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>helix</region_name>
					<region_start>107</region_start>
					<region_end>110</region_end>
				</region>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>helix</region_name>
					<region_start>131</region_start>
					<region_end>136</region_end>
				</region>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>strand</region_name>
					<region_start>2</region_start>
					<region_end>8</region_end>
				</region>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>strand</region_name>
					<region_start>15</region_start>
					<region_end>22</region_end>
				</region>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>strand</region_name>
					<region_start>29</region_start>
					<region_end>36</region_end>
				</region>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>strand</region_name>
					<region_start>41</region_start>
					<region_end>48</region_end>
				</region>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>strand</region_name>
					<region_start>83</region_start>
					<region_end>89</region_end>
				</region>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>strand</region_name>
					<region_start>95</region_start>
					<region_end>101</region_end>
				</region>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>strand</region_name>
					<region_start>116</region_start>
					<region_end>120</region_end>
				</region>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>strand</region_name>
					<region_start>143</region_start>
					<region_end>148</region_end>
				</region>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>strand</region_name>
					<region_start>150</region_start>
					<region_end>151</region_end>
				</region>
				<region>
					<region_type>pfam</region_type>
					<region_id>PF00080</region_id>
					<region_name>Copper/zinc superoxide dismutase (SODC)</region_name>
					<region_start>15</region_start>
					<region_end>150</region_end>
				</region>
			</regions>
		</chain>
		<chain>
			<id>F</id>
			<name>Superoxide dismutase [Cu-Zn]</name>
			<source_organism>Homo sapiens</source_organism>
			<uniprot>
				<id>P00441</id>
				<start>2</start>
				<end>154</end>
				<coverage>99%</coverage>
				<sequence>MATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ</sequence>
				<length>154</length>
			</uniprot>
			<regions>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>helix</region_name>
					<region_start>55</region_start>
					<region_end>61</region_end>
				</region>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>helix</region_name>
					<region_start>133</region_start>
					<region_end>138</region_end>
				</region>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>strand</region_name>
					<region_start>3</region_start>
					<region_end>10</region_end>
				</region>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>strand</region_name>
					<region_start>14</region_start>
					<region_end>22</region_end>
				</region>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>strand</region_name>
					<region_start>29</region_start>
					<region_end>36</region_end>
				</region>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>strand</region_name>
					<region_start>41</region_start>
					<region_end>48</region_end>
				</region>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>strand</region_name>
					<region_start>83</region_start>
					<region_end>89</region_end>
				</region>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>strand</region_name>
					<region_start>95</region_start>
					<region_end>101</region_end>
				</region>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>strand</region_name>
					<region_start>116</region_start>
					<region_end>120</region_end>
				</region>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>strand</region_name>
					<region_start>143</region_start>
					<region_end>148</region_end>
				</region>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>strand</region_name>
					<region_start>150</region_start>
					<region_end>151</region_end>
				</region>
				<region>
					<region_type>pfam</region_type>
					<region_id>PF00080</region_id>
					<region_name>Copper/zinc superoxide dismutase (SODC)</region_name>
					<region_start>15</region_start>
					<region_end>150</region_end>
				</region>
			</regions>
		</chain>
	</macromolecules>
	<evidence>
		<evidence_level>Direct evidence</evidence_level>
		<evidence_coverage>The full structure participates in mutual synergistic folding.</evidence_coverage>
		<sequence_domain>-</sequence_domain>
		<complex_evidence>CD measurements and a global analysis decomposition of the time-resolved fluorescence decay over denaturant concentration shows the presence of an intermediate in the unfolding of human SOD by guanidinium hydrochloride. Considering previous measurements of partially denatured HSOD as a function of protein concentration (PMID:1510915), these results strongly suggest that the unfolding intermediate is a monomer that displays a molten globule state (PMID:8298055).</complex_evidence>
		<chain_evidence>
			<chain_id>A</chain_id>
			<support>N/A</support>
		</chain_evidence>
		<chain_evidence>
			<chain_id>F</chain_id>
			<support>N/A</support>
		</chain_evidence>
	</evidence>
</entry>
